28 Jan 2021

Nuevos avances en Reumatología e implicaciones terapéuticas 2021

Stay Tuned!

Our Newsletter
Event Finished
Do you want to know the next activities activities on Reumatología?

Join our newsletter list to be updated on upcoming activities.

The progressive understanding of the human immune system and the pathophysiology of immune-mediated diseases (IMIDs) have led us to consider a large number of new targets and the identification of numerous potential therapeutic targets for patients with IMIDs. Moreover, the possible involvement of the exogenome in the activation of the immune system and its role in the different IMIDs is today one of the most interesting scientific challenges.

The different lectures, led by renowned experts, will provide a comprehensive overview of the management of rheumatoid arthritis and the spondyloarthritis family with special emphasis on all the new imaging and biomarker data useful to move towards personalized medicine. The conference will also serve to evaluate in depth the clinical and therapeutic implications of the microbiome in these diseases.


Scientific Coordinators

Jordi Gratacós

Director of the Rheumatology Service.

Hospital Parc Taulí, Sabadell, Spain.

More Info

Eduardo Collantes

Emeritus Professor and Co-Responsible Investigator

University of Cordoba and IMIBIC, Cordoba, Spain. 

More Info

José María Álvaro-Gracia

Director of the Rheumatology Service Hospital Gregorio Marañón, Madrid.

More Info


Activity accredited by the Consell Català de Formació Continua de les Professions Sanitàries-Comisión de Formación Continuada de Sistema Nacional de Salud. 0,6 Credits. Record: 09/028749-MD.



    Your Cart
    Your cart is emptyReturn to Shop